All Stories

  1. A Randomized Trial of Shunting for Idiopathic Normal-Pressure Hydrocephalus
  2. Brain and cerebrospinal fluid 3D center of mass shift after spaceflight
  3. Adult Hydrocephalus Clinical Subtypes
  4. Guidelines for Diagnosis and Management of Idiopathic Normal Pressure Hydrocephalus
  5. Research priorities for improving cognitive and neuropsychological outcomes in hydrocephalus
  6. Ethically cleared to launch?
  7. Introduction. Adult hydrocephalus: advancements in diagnosis, treatment, and patient outcomes
  8. Placebo-Controlled Effectiveness of Idiopathic Normal Pressure Hydrocephalus Shunting: A Randomized Pilot Trial
  9. Safety and effectiveness of the assessment and treatment of idiopathic normal pressure hydrocephalus in the Adult Hydrocephalus Clinical Research Network
  10. Cognitive and gait outcomes after primary endoscopic third ventriculostomy in adults with chronic obstructive hydrocephalus
  11. Reducing intracranial pressure by reducing central venous pressure: assessment of potential countermeasures to spaceflight-associated neuro-ocular syndrome
  12. Daily generation of a footward fluid shift attenuates ocular changes associated with head-down tilt bed rest
  13. Extended lumbar drainage in idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis of diagnostic test accuracy
  14. The clinical spectrum of hydrocephalus in adults: report of the first 517 patients of the Adult Hydrocephalus Clinical Research Network registry
  15. Health care transition in pediatric neurosurgery: a consensus statement from the American Society of Pediatric Neurosurgeons
  16. Nowhere to Go: The Challenge of Health Care Transition for Youth with Hydrocephalus
  17. Current Update on Treatment Strategies for Idiopathic Normal Pressure Hydrocephalus
  18. Improving health care transition and longitudinal care for adolescents and young adults with hydrocephalus: report from the Hydrocephalus Association Transition Summit
  19. Mischaracterization of Spaceflight-Associated Neuro-ocular Syndrome
  20. Lower body negative pressure to safely reduce intracranial pressure
  21. Lawful physician-hastened death
  22. Effect of gravity and microgravity on intracranial pressure
  23. Hydrocephalus in the Elderly: Diagnosis of Idiopathic Normal Pressure Hydrocephalus
  24. Hydrocephalus in the Elderly: Surgical Management of Idiopathic Normal Pressure Hydrocephalus
  25. Distortion Product Otoacoustic Emissions and Intracranial Pressure During CSF Infusion Testing
  26. Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus
  27. Cerebral spinal fluid dynamics: effect of hypoxia and implications for high-altitude illness
  28. An update on research priorities in hydrocephalus: overview of the third National Institutes of Health-sponsored symposium “Opportunities for Hydrocephalus Research: Pathways to Better Outcomes”
  29. Preventing Distal Catheter Obstruction in Laparoscopic Ventriculoperitoneal Shunt Placement in Adults: The “Falciform Technique”
  30. Comment: The trouble with “n” in normal-pressure hydrocephalus
  31. A computerized neuropsychological test battery designed for idiopathic normal pressure hydrocephalus
  32. Diagnosis and management of idiopathic normal-pressure hydrocephalus
  33. Influence of comorbidities in idiopathic normal pressure hydrocephalus — research and clinical care. A report of the ISHCSF task force on comorbidities in INPH
  34. IDEAL for CCSVI Research—Reply
  35. Hydrodynamics of the Certas™ programmable valve for the treatment of hydrocephalus
  36. No Endovascular Innovation Without Evaluation in Chronic Cerebrospinal Venous Insufficiency
  37. Ethical Considerations in Hydrocephalus Research That Involves Children and Adults
  38. Low-Dose Recombinant Tissue-Type Plasminogen Activator Enhances Clot Resolution in Brain Hemorrhage
  39. Idiopathic Normal Pressure Hydrocephalus
  40. Cognitive Impairment in Patients with Pseudotumor Cerebri Syndrome
  41. Sedation for the imminently dying: Survey results from the AAN Ethics Section
  42. Neuroenhancement: Wisdom of the Masses or ”False Phronesis”?
  43. The Role of the Neurologist in the Longitudinal Management of Normal Pressure Hydrocephalus
  44. Predicting the Outcome of Shunt Surgery in Normal Pressure Hydrocephalus
  45. The public's perspectives on advance directives: Implications for state legislative and regulatory policy
  46. A CROSS-SECTIONAL STUDY OF BONE HEALTH IN MULTIPLE SCLEROSIS
  47. Sedation for the imminently dying
  48. ETHICAL PERSPECTIVES IN NEUROLOGY
  49. Responding to requests from adult patients for neuroenhancements
  50. CEREBROSPINAL FLUID DRAINAGE AND DYNAMICS IN THE DIAGNOSIS OF NORMAL PRESSURE HYDROCEPHALUS
  51. RADIONUCLIDE SHUNT PATENCY STUDY FOR EVALUATION OF SUSPECTED VENTRICULOPERITONEAL SHUNT MALFUNCTION IN ADULTS WITH NORMAL PRESSURE HYDROCEPHALUS
  52. Justified Use of Painful Stimuli in the Coma Examination: A Neurologic and Ethical Rationale
  53. Frequency of Sustained Intracranial Pressure Elevation during Treatment of Severe Intraventricular Hemorrhage
  54. What We Gain by Measuring Head Circumference
  55. Normal pressure hydrocephalus: long-term outcome after shunt surgery
  56. Regulating Physician Expert Witness Testimony
  57. DIAGNOSIS, TREATMENT, AND ANALYSIS OF LONG-TERM OUTCOMES IN IDIOPATHIC NORMAL-PRESSURE HYDROCEPHALUS
  58. INFECTIOUS COMPLICATIONS OF TEMPORARY SPINAL CATHETER INSERTION FOR DIAGNOSIS OF ADULT HYDROCEPHALUS AND IDIOPATHIC INTRACRANIAL HYPERTENSION
  59. Heritable essential tremor‐idiopathic normal pressure hydrocephalus (ETINPH)
  60. POSITION STATEMENT ON LAWS AND REGULATIONS CONCERNING LIFE-SUSTAINING TREATMENT, INCLUDING ARTIFICIAL NUTRITION AND HYDRATION, FOR PATIENTS LACKING DECISION-MAKING CAPACITY
  61. Objective Assessment of Gait in Normal-Pressure Hydrocephalus
  62. Sensitivity and predictive value of occupational and physical therapy assessments in the functional evaluation of patients with suspected normal pressure hydrocephalus
  63. Priorities for hydrocephalus research: report from a National Institutes of Health–sponsored workshop
  64. Extrapyramidal signs in normal pressure hydrocephalus: an objective assessment
  65. Influence of shunt surgery on healthcare expenditures of elderly fee-for-service Medicare beneficiaries with hydrocephalus
  66. Position statement on laws and regulations concerning life-sustaining treatment, including artificial nutrition and hydration, for patients lacking decision-making capacity
  67. EVALUATION AND TREATMENT OF PATIENTS WITH SUSPECTED NORMAL PRESSURE HYDROCEPHALUS ON LONG-TERM WARFARIN ANTICOAGULATION THERAPY
  68. ETHICAL PERSPECTIVES IN NEUROLOGY
  69. Diagnosis, Treatment, and Analysis of Long-term Outcomes in Idiopathic Normal-Pressure Hydrocephalus
  70. Characteristics and Reversibility of Dementia in Normal Pressure Hydrocephalus
  71. Prior CSF shunting increases the risk of endoscopic third ventriculostomy failure in the treatment of obstructive hydrocephalus in adults
  72. Unbefriended
  73. Normal Pressure Hydrocephalus
  74. Evidence that congenital hydrocephalus is a precursor to idiopathic normal pressure hydrocephalus in only a subset of patients
  75. Ethical Issues in Critical Care and Cardiac Arrest: Clinical Research, Brain Death, and Organ Donation
  76. Neurologic prognosis and withdrawal of life support after resuscitation from cardiac arrest
  77. The diagnosis and treatment of idiopathic normal pressure hydrocephalus
  78. Genetics of human hydrocephalus
  79. Ethical Issues in Infectious Diseases of the Nervous System
  80. What we don’t (but should) know about hydrocephalus
  81. Who will make medical decisions for you if you can’t make them yourself?
  82. American Academy of Neurology qualifications and guidelines for the physician expert witness
  83. January 10 Highlight and Commentary
  84. Demographic Factors Influence Cognitive Recovery After Shunt for Normal-Pressure Hydrocephalus
  85. A COMPARISON OF GAIT ASSESSMENT METHODS: TINETTI AND GAITRITE ELECTRONIC WALKWAY
  86. Diagnosis, Treatment, and Analysis of Long-term Outcomes in Idiopathic Normal-Pressure Hydrocephalus
  87. A Unique Neurocognitive Profile Differentiates Idiopathic Normal-pressure Hydrocephalus from Neurodegenerative Dementia: A Novel Guide for Shunt Surgery
  88. The syndrome of hydrocephalus in young and middle-aged adults (SHYMA)
  89. The use of ventriculoperitoneal shunts for uncontrollable intracranial hypertension without ventriculomegally secondary to HIV-associated cryptococcal meningitis
  90. Baseline Neuropsychological Profile and Cognitive Response to Cerebrospinal Fluid Shunting for Idiopathic Normal Pressure Hydrocephalus
  91. Cerebrospinal fluid shunt placement for pseudotumor cerebri—associated intractable headache: predictors of treatment response and an analysis of long-term outcomes
  92. Cognitive Recovery in Idiopathic Normal Pressure Hydrocephalus After Shunt
  93. Reviews
  94. Utility of CSF Pressure Monitoring to Identify Idiopathic Intracranial Hypertension without Papilledema in Patients with Chronic Daily Headache
  95. The physician’s role in discussing organ donation with families*
  96. Irreconcilable differences?*
  97. Ventilatory care in myasthenia gravis crisis: Assessing the baseline adverse event rate*
  98. Interhemispheric Intracranial Pressure Gradients in Massive Cerebral Infarction
  99. Spinal catheter insertion via seated lumbar puncture using a massage chair
  100. Symptomatic vasospasm diagnosis after subarachnoid hemorrhage: Evaluation of transcranial Doppler ultrasound and cerebral angiography as related to compromised vascular distribution
  101. The integration of palliative care and critical care: one vision, one voice
  102. Ventriculitis Complicating Use of Intraventricular Catheters in Adult Neurosurgical Patients
  103. Blood Clot Resolution in Human Cerebrospinal Fluid: Evidence of First-order Kinetics
  104. Blood Clot Resolution in Human Cerebrospinal Fluid: Evidence of First-order Kinetics
  105. Effect of Age on Cerebral Blood Flow Velocity and Incidence of Vasospasm After Aneurysmal Subarachnoid Hemorrhage
  106. Ventriculopleural shunt obstruction and positive-pressure ventilation
  107. Report of the Council on Scientific Affairs
  108. Diagnostic Impact of Early Transcranial Doppler Ultrasonography on the TOAST Classification Subtype in Acute Cerebral Ischemia
  109. Treatment of Intraventricular Hemorrhage With Urokinase
  110. Use of opioids to treat chronic, noncancer pain
  111. Preventing Prion Transmission in Corneal Transplants
  112. Endotracheal suctioning and cerebral ischemia in traumatic brain injury: The "phantom menace?"
  113. Risk of Transmission of Bovine Spongiform Encephalopathy to Humans in the United States<SUBTITLE>Report of the Council on Scientific Affairs</SUBTITLE>
  114. Intracranial hemorrhage
  115. Manganese in Gasoline
  116. Reducing Sleepiness on the Roads and on the Wards
  117. Report of the Council on Scientific Affairs: Unlabeled Indications of Food and Drug Administration-Approved Drugs
  118. Sleepiness, Driving, and Motor Vehicle Crashes
  119. Treatment of refractory intracranial hypertension with 23.4% saline
  120. Heat-Related Illness During Extreme Weather Emergencies
  121. Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
  122. Silicone Elastomer Cerebrospinal Fluid Shunt Systems
  123. Clinical Research: Assessing the Future in a Changing Environment; Summary Report of Conference Sponsored by the American Medical Association Council on Scientific Affairs, Washington, DC, March 1996
  124. Comparison of Pcsf Monitoring and Controlled CSF Drainage Diagnose Normal Pressure Hydrocephalus
  125. Evaluation of Shunt Function in Patients Who are Never Better, or Better than Worse after Shunt Surgery for NPH
  126. Magnetic Resonance Imaging, Unstable Intracranial Pressure and Clinical Outcome in Patients with Normal Pressure Hydrocephalus
  127. Educational and Informational Strategies to Reduce Pesticide Risks
  128. Good Care of the Dying Patient
  129. Epidemic Infectious Disease Risks: Striving for Perspective
  130. Female Genital Mutilation
  131. Prolonged pentobarbital and phenobarbital coma for refractory generalized status epilepticus
  132. Cerebrospinal fluid circulation, cerebral edema, and intracranial pressure